JFG
RARE icon

Jefferies Financial Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Jefferies Financial Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31M Buy
929,626
+914,138
+5,902% +$22.7M 0.2% 97
2026
Q1 		$324K Sell
15,488
-461,604
-97% -$10.4M ﹤0.01% 1355
2025
Q4 		$11M Buy
+477,092
New +$15.7M 0.06% 300
2024
Q3 		– Sell
-10,250
Closed -$421K – 1710
2024
Q2 		$421K Buy
+10,250
New +$438K ﹤0.01% 1016

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Jefferies Financial Group's RARE Position: Q2 2026 in Review

Jefferies Financial Group increased its Ultragenyx Pharmaceutical (RARE) stake by 5,902% in Q2 2026, buying an estimated $22.7M and bringing the position to 929,626 shares worth $31M. The position accounts for 0.2% of the portfolio, ranked #97.

Jefferies Financial Group first reported a position in RARE in Q2 2024 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Jefferies Financial Group held 929,626 shares of Ultragenyx Pharmaceutical worth $31M as of Q2 2026.
  • Jefferies Financial Group bought 914,138 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $22.7M.
  • Ultragenyx Pharmaceutical made up 0.2% of Jefferies Financial Group's portfolio in Q2 2026, its #97 holding.
  • Jefferies Financial Group first reported a position in Ultragenyx Pharmaceutical in Q2 2024 and has held it in 4 quarters since.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.